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Herpesvirus-associated ubiquitin-specific protease (HAUSP, also known as USP7), a deubiquitylating enzyme of the
ubiquitin-specific processing protease family, specifically deubiquitylates both p53 and MDM2, hence playing an
important yet enigmatic role in the p53–MDM2 pathway. Here we demonstrate that both p53 and MDM2 specifically
recognize the N-terminal tumor necrosis factor–receptor associated factor (TRAF)–like domain of HAUSP in a mutually
exclusive manner. HAUSP preferentially forms a stable HAUSP–MDM2 complex even in the presence of excess p53. The
HAUSP-binding elements were mapped to a peptide fragment in the carboxy-terminus of p53 and to a short-peptide
region preceding the acidic domain of MDM2. The crystal structures of the HAUSP TRAF-like domain in complex with
p53 and MDM2 peptides, determined at 2.3-A ˚ and 1.7-A ˚ resolutions, respectively, reveal that the MDM2 peptide
recognizes the same surface groove in HAUSP as that recognized by p53 but mediates more extensive interactions.
Structural comparison led to the identification of a consensus peptide-recognition sequence by HAUSP. These results,
together with the structure of a combined substrate-binding-and-deubiquitylation domain of HAUSP, provide
important insights into regulation of the p53–MDM2 pathway by HAUSP.
Citation: Hu M, Gu L, Li M, Jeffrey PD, Gu W, et al. (2006) Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the
P53–MDM2 pathway. PLoS Biol 4(2): e27.
Introduction
The p53 tumor-suppressor protein is a sequence-speciﬁc
transcription factor that responds to a wide variety of cellular
stress signals [1–3]. The normal function of p53 is indispen-
sable to many cellular processes, such as cell-cycle control and
apoptosis. It is generally believed that p53 activity is primarily
controlled at the level of post-translational modiﬁcation,
particularly ubiquitylation [4–6]. In normal cells, p53 is
maintained at a low level mainly through MDM2-mediated
ubiquitylation and subsequent degradation [7–9]. MDM2 is a
RING-ﬁnger E3 ubiquitin ligase [10] that speciﬁcally interacts
with p53 through its N-terminal p53-binding domain [11–14].
The C-terminal RING-ﬁnger motif of MDM2 not only
promotes p53 ubiquitylation [10,15], but also targets MDM2
itself for auto-ubiquitylation and subsequent degradation
[10,15]. In addition, MDM2 is also a negative regulator of p53-
mediated transcriptional activity [16]. The MDM2 gene is a
transcriptional target of p53 [17–19], so activation of the
MDM2 gene by p53 would lead to repression of p53 activity.
The existence of this auto-regulatory feedback loop between
MDM2 and p53 adds a complex feature to the p53–MDM2
pathway and makes MDM2 one of the most important
regulators of p53 activity.
As a countermeasure of protein ubiquitylation, protein
deubiquitylation has also been recognized as an important
regulatory step in many cellular processes [20–23]. Most
deubiquitylating enzymes (DUBs) are cysteine proteases that
speciﬁcally cleave ubiquitin from its conjugates. Growing
evidence shows that DUBs can act at many different stages
throughout the ubiquitin–proteasome pathway and thus play
a key role in maintaining the normal functions of the
ubiquitin-dependent system. There are ﬁve conserved fami-
lies of DUBs, of which the ubiquitin-speciﬁc processing
proteases (UBPs) constitute the largest family with more than
60 members [20–23]. A unique feature for UBPs is that they
contain divergent N- and/or C- terminal extensions, suggest-
ing putative substrate-recognition modules. However, only a
few UBPs with speciﬁc substrates have been identiﬁed and,
consequently, the mechanisms by which UBPs recognize
substrates remain largely unknown.
Using an afﬁnity-based approach, herpesvirus-associated
ubiquitin-speciﬁc protease (HAUSP, also known as USP7) was
identiﬁed as a novel p53-interacting protein [24,25]. HAUSP
directly binds to and deubiquitylates p53 both in vivo and in
vitro. Expression of HAUSP was shown to stabilize p53 in vivo
and to promote p53-dependent apoptosis and cell-growth
arrest [24]. These observations revealed an important
mechanism for p53 stabilization and identiﬁed HAUSP as
the ﬁrst mammalian UBP with a known substrate. More
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PLoS BIOLOGYrecently, HAUSP was shown to physically interact with MDM2
in a p53-independent manner [26–28]. HAUSP can deubi-
quitylate MDM2, both in vivo and in vitro, and is required for
the stability of MDM2 in normal cells [26–28].
The observation that HAUSP can directly interact with and
deubiquitylate both p53 and MDM2 creates a conundrum:
how can HAUSP stabilize p53 while at the same time being
able to stabilize MDM2, which is primarily responsible for the
destruction of p53? One possibility is that only one of the two
proteins, p53 and MDM2, represents a physiologically
relevant target for HAUSP [27,28]. Supporting this notion,
increased ubiquitylation of MDM2 was observed in the
HAUSP-ablated cells, which consequently resulted in the
stabilization of p53 [26–28]. Another contrasting possibility is
that HAUSP can target both p53 and MDM2 for deubiqui-
tylation and thus may play a dynamic role in the p53–MDM2
pathway [26]. In both scenarios, in order to decipher the role
of HAUSP in the p53–MDM2 pathway, it is essential to
understand how HAUSP speciﬁcally recognizes p53 and
MDM2 and to understand the relationships involved in these
two recognition events.
The N-terminal tumor necrosis factor–receptor associated
factor (TRAF)–like domain (residues 53–208) of HAUSP was
previously shown to speciﬁcally interact with the C-terminal
sequences of p53 [29]. A recent paper reported the crystal
structures of the TRAF-like domain of HAUSP in isolation
and in complex with a peptide derived from EBNA1 [30].
Although the structure of the HAUSP TRAF-like domain
closely resembles that of other known TRAF domains,
recognition of the EBNA1 peptide by HAUSP is different
from that observed in other TRAF–peptide complexes [30].
Interestingly, analysis of the nuclear magnetic resonance
chemical shifts suggested that a p53 peptide might bind to the
same general location on the surface of the HAUSP TRAF-
like domain as the peptide derived from EBNA1 [30].
In this paper, we report the biochemical and structural
basis on the recognition of p53 and MDM2 by HAUSP. We
show that both p53 and MDM2 bind to, in a mutually
exclusive manner, the N-terminal TRAF-like domain of
HAUSP. MDM2 exhibits a much higher binding afﬁnity, as
it efﬁciently out-competes excess p53 for binding to HAUSP
in a competition assay. We localized the HAUSP-binding
elements to short-peptide fragments in p53 and in MDM2
and determined the crystal structures of HAUSP TRAF-like
domain bound to such peptides. These structures reveal the
molecular basis for the differential binding of p53 and MDM2
to HAUSP, which allows the derivation of a consensus
peptide-recognition sequence for HAUSP. These ﬁndings
have important ramiﬁcations for understanding the role of
HAUSP in the p53–MDM2 pathway.
Results
Structure of the HAUSP TRAF-Like Domain
We previously mapped the p53-binding element of HAUSP
to its N-terminal residues 53–208 [29], which shares signiﬁ-
cant homology to the TRAF domain [31]. We crystallized this
domain (residues 53–206) and determined its structure at
1.65-A ˚ resolution (Tables 1–3; Figure 1A). As previously
reported [30], the HAUSP TRAF-like domain adopts an eight-
stranded anti-parallel b-sandwich structure, with strands b1,
b5, b6, and b8 in one sheet and strands b2, b3, b4, and b7i n
the other (Figure 1A). The overall structure of the HAUSP
TRAF-like domain closely resembles the TRAF-C domain of
the TRAF family of proteins [32–36]. In addition, the HAUSP
TRAF-like domain contains a shallow surface groove in the
middle of the b-sandwich (Figure 1A), which corresponds to
the region where the receptor peptides bind [32–36].
Despite overall structural similarity, amino acid composi-
tion in the putative substrate-binding groove of HAUSP
differs signiﬁcantly from that in TRAF2 (Figure 1B). For
example, a set of peptide-interacting residues in TRAF2,
including Arg393, Tyr395, Asp399, Phe447, Ser453, Ser454,
Ser455, and Ser467, are highly conserved among TRAF1, 2, 3,
and 5 [32–36]. However, most of these conserved residues are
no longer retained in the HAUSP TRAF-like domain,
suggesting different peptide-binding speciﬁcity. Moreover,
the residues mediating peptide recognition in TRAF6,
Arg392, Phe471, and Tyr473, are also missing in the HAUSP
N-terminal domain structure [34] (Figure 1B). These obser-
vations indicate that the HAUSP TRAF-like domain may
represent a new type of peptide-binding motif in the TRAF
family.
Structural Basis of p53 Recognition by HAUSP
We previously showed that the HAUSP TRAF-like domain
stably interacts with a C-terminal peptide fragment (residues
357–382) of p53 and that deletion of 11 amino acids (residues
357–367) in p53 resulted in a complete loss of interaction
with HAUSP [29]. Using an in vitro interaction assay, we
performed mutagenesis to further deﬁne the HAUSP-binding
element in p53 (Figure 2A). All mutant p53 fragments were
individually puriﬁed to homogeneity and were examined for
binding to HAUSP using gel ﬁltration. The results are
summarized in Figure 2A. The wild-type p53 fragment
(residues 325–363), which exists as a constitutive tetramer in
solution, formed a stable complex with HAUSP. Mutations of
residues 357, 358, and 363 did not affect the ability of p53
(residues 325–367) to interact with HAUSP.
In contrast, mutation of Pro359, Gly361, or Ser362 in p53
(residues 325–367) resulted in abrogation of its interaction
with the HAUSP TRAF-like domain (Figure 2A). For example,
while the wild-type p53 (residues 325–367) formed a stable
complex with HAUSP (residues 53–206) as judged by their co-
elution on gel ﬁltration (Figure 2A, upper-right panel), the
mutant p53 (S362A) and HAUSP (residues 53–206) did not
interact with each other (Figure 2A, lower-right panel). It
should be noted that, because the elution volume for HAUSP
(residues 53–206) alone is very similar to that of the
tetrameric p53 (residues 325–367) alone, the tetrameric
mutant p53 (S362A) and HAUSP (residues 53–206) were
present in similar fractions from gel ﬁltration despite lack of
interactions (Figure 2A, lower-right panel). Together, these
observations suggest that the minimal HAUSP-binding
element is within amino acids 359–363 of p53. Interestingly,
calibration of the gel ﬁltration column suggests that only one
molecule of the HAUSP TRAF-like domain (18 kDa) is likely
to be bound to a tetramer (19.6 kDa) of the p53 fragment
(residues 325–367), as the complex was eluted with an
apparent molecular weight of approximately 39 kDa. The
precise stoichiometry between HAUSP and p53 should be
determined by additional conclusive experimental ap-
proaches.
To elucidate the mechanism by which p53 recognizes
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Recognition of p53 and MDM2 by HAUSPHAUSP, we launched rigorous trials aimed at crystallizing the
HAUSP TRAF-like domain bound to a synthetic p53 peptide.
However, such effort did not yield crystals that are suitable
for X-ray-diffraction studies. To facilitate formation of a
stable p53–HAUSP complex, we generated a chimeric protein
with the C-terminus of the HAUSP TRAF-like domain
(residues 53–199) fused to ten amino acids corresponding to
p53 residues 359–368. We reasoned that such design would
ensure a 1:1 stoichiometry between HAUSP and the p53
peptide. Indeed this engineering effort proved effective, and
diffraction-quality crystals were successfully obtained. The
structure of the HAUSP TRAF-like domain bound to p53
(residues 359–368) was determined at 2.3-A ˚ resolution by
molecular replacement (Table 4; Figure 2B).
The p53 peptide binds to the shallow surface groove near
one edge of the b-sandwich in the TRAF-like domain (Figure
2B). Only four contiguous amino acids of p53, Pro359-
Gly360-Gly361-Ser362, make speciﬁc interactions to residues
in HAUSP, whereas Arg363 adopts a well-deﬁned conforma-
tion but is not directly involved in HAUSP recognition
(Figure 2C). At the N-terminus, the side chain of Pro359 is
nestled in a hydrophobic pocket at the edge of the b-
sandwich, which is formed by the backbone Ca atom of
Gly166 and the hydrophobic side chains of Phe167, Trp165,
and Ile154 (Figure 2C). At the C-terminus, the carboxylate
side chain of Asp164 accepts two hydrogen bonds from the
amide and the hydroxyl groups of Ser362. In addition, the
side chain of Ser362 makes van der Waals contacts to Phe118.
In the center of the bound p53 peptide, the amide and
carbonyl groups of Gly360 are hydrogen-bonded to the main-
chain groups of Gly166 from HAUSP (Figure 2C). The main-
chain Ca of Gly360 makes van der Waals contacts to Trp165
in HAUSP. Residues 364–368 of p53 are disordered in the
crystals and do not contribute to HAUSP binding. A previous
report identiﬁed a number of amino acid residues in the
HAUSP TRAF-like domain that may play important roles in
binding to p53 [30]. Our structure shows how the majority of
these residues interact with speciﬁc residues in p53.
The structural observations are fully consistent with our
mutagenesis data (Figure 2A and 2C). For example, Pro359
and Ser362 in the p53 peptide anchor its interaction with the
HAUSP TRAF-like domain (Figure 2C); missense mutation of
Pro359 or Ser362 in p53 abolished its binding to HAUSP
(Figure 2A). To further corroborate the structural ﬁndings,
we also performed additional mutagenesis on the HAUSP
TRAF-like domain. Mutation of Trp165 and Phe167 in
HAUSP, both involved in the hydrophobic pocket that
accommodates Pro359 of p53, resulted in a complete loss of
binding to p53 (unpublished data). Similarly, mutation of
Asp164, which forms hydrogen bonds with S362 of p53, also
signiﬁcantly weakened the ability of HAUSP to bind to p53
(unpublished data).
Mapping HAUSP–MDM2 Interactions
MDM2 is known to speciﬁcally associate with HAUSP and
represents a physiological substrate for HAUSP-mediated
deubiquitylating activity. To elucidate the mechanism by
which HAUSP recognizes MDM2, we ﬁrst sought to identify
the minimal domain in HAUSP that is responsible for
binding to MDM2, and the results are summarized in Figure
Table 1. Summary of Crystallographic Analysis on HAUSP TRAF-Like Domain
Dataset Native HAUSP (53–206) SeMet k1 (Peak) SeMet k2 (Inflection) SeMet k3 (Remote)
Beamline NSLS X25 NSLS X12C NSLS X12C NSLS X12C
Wavelength (A ˚) 1.1 0.9794 0.9797 0.9500
Resolution (A ˚) 99–1.60 99–2.40 99–2.40 99–2.40
Unique reflections 20,180 5,801 5,768 5,667
Data redundancy 6.5 7.1 7.0 7.0
Completeness (%) 95.2 90.1 89.5 87.5
Completeness (outer shell) 60.0 48.6 47.5 40.4
I/r (outer shell) 36.8 (6.3) 15.3 (2.9) 14.4 (2.8) 13.4 (2.3)
Rsym (outer shell) 0.048 (0.203) 0.11 (0.31) 0.099 (0.29) 0.12 (0.40)
Anomalous difference (%) n/a 7.0 6.6 7.2
Rcullis 0.69 0.68 0.66
Phasing power (centric/acentric) 1.57/1.28 1.36/1.13 1.71/1.36
Overall figure of merit (20–2.4 A ˚): 0.55.
Rsym¼RhRi j Ih,i Ih j /RhRi Ih,i, where Ih is the mean intensity of the i observations of symmetry-related reflections of h. Rcryst¼
P
j Fobs Fcalc j /
P
Fobs, where Fobs¼FP, and Fcalc is the calculated protein-structure factor from the atomic model
(Rfree was calculated with 10% of the reflections). Phasing power¼[(FH(calc)
2/(FPH(obs) FPH(calc) )
2]
1/2 , where FPH(obs) and FPH(calc) are the observed and calculated derivative-structure factors, respectively. Rcullis¼
P
jj FPH 6 FP j FH(calc) j /
P
j FPH




P(a) ., where P(a) is the probability distribution for the phase a. RMSD in bond lengths and angles are the deviations from ideal values.
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DOI: 10.1371/journal.pbio.0040027.t002
PLoS Biology | www.plosbiology.org February 2006 | Volume 4 | Issue 2 | e27 0230
Recognition of p53 and MDM2 by HAUSP3A. To our surprise, the N-terminal TRAF-like domain of
HAUSP (residues 1–206) was found to form a stable complex
with MDM2 (residues 170–423). This result indicates that the
same domain of HAUSP that interacts with p53 is also
responsible for binding to MDM2. Neither the central
isopeptidase domain nor the C-terminal extension of HAUSP
was required for binding to MDM2 (residues 170–423) (Figure
3A).
Next, we mapped the minimal HAUSP-binding element in
MDM2, and the results are summarized in Figure 3B. The full-
length human MDM2 (known as HDM2), containing 491
amino acids [37], can be divided into four major conserved
regions: an N-terminal domain responsible for binding to
p53, a highly acidic region that is involved in binding to
multiple proteins, a putative Cys4-type zinc-ﬁnger domain,
and a RING-ﬁnger domain responsible for the E3 ubiquitin
ligase activity of MDM2 [37]. We ﬁrst found that a 33-kDa
fragment of MDM2 (residues 170–432) formed a stable
complex with the full-length HAUSP as well as with the
HAUSP N-terminal TRAF-like domain. Next, we generated a
series of deletion variants of MDM2 and assayed their
interactions with the HAUSP TRAF-like domain using a gel
ﬁltration assay. Neither the central acidic region nor the zinc-
ﬁnger domain of MDM2 interacted with HAUSP (residues 53–
206). An MDM2 fragment encompassing residues 223–289 or
residues 170–232 formed a stable complex with the HAUSP
TRAF-like domain (residues 53–206), suggesting an essential
role of amino acids 223–232 in MDM2 (Figure 3B). Support-
ing this notion, the ten-amino acid MDM2 fragment (residues
223–232) was found to form a stable complex with the
HAUSP TRAF-like domain (unpublished data).
Mutually Exclusive HAUSP Binding by p53 and by MDM2
The fact that both a p53 C-terminal peptide fragment and a
short-peptide sequence preceding the acidic domain of
MDM2 bind to the N-terminal TRAF-like domain of HAUSP
raised an intriguing possibility: HAUSP binding by p53 and
by MDM2 might be mutually exclusive. To test this
hypothesis, we performed an in vitro competition assay using
gel ﬁltration chromatography. The HAUSP TRAF-like do-
main (residues 1–206) was incubated with one molar
equivalence of MDM2 (residues 208–289) in the presence of
10-fold molar equivalence of p53 (residues 351–382), and
then the mixture was subjected to a gel ﬁltration analysis.
Despite a 10-fold excess of the p53 peptide over MDM2, the
MDM2 fragment, but not the p53 peptide, formed a stable
complex with HAUSP (residues 1–206) (Figure 3C). This result
suggests that MDM2 binds to HAUSP with a higher afﬁnity
than does p53.
To assess the strength of HAUSP binding by p53 and by
MDM2, we measured the binding afﬁnity between the HAUSP
TRAF-like domain (residues 53–206) and a p53 peptide
(residues 351–382) or an MDM2 peptide (residues 208–242)
using isothermal titration calorimetry (ITC). Under identical
experimental conditions, the MDM2 peptide bound to the
HAUSP TRAF-like domain with a dissociation constant of 3
lM, 7-fold tighter than that of the p53 peptide (Figure 3D).
Thus these experiments conﬁrm the competitive binding
edge of MDM2 over p53. The observed binding afﬁnity
between the p53 peptide and the HAUSP TRAF-like domain
is in agreement with a previous report [30]. It should be noted
that the binding afﬁnity of the full-length MDM2 is likely to
be higher than the value reported here, because the full-
length MDM2 protein contains at least two more binding sites
for HAUSP (see Discussion), and the multiple binding sites
Figure 1. Structure of the HAUSP N-Terminal TRAF-Like Domain
(A) Structure of the HAUSP TRAF-like domain in a ribbon diagram (left)
and a surface representation (right). Secondary structural elements (left)
and the putative substrate-binding groove (right) are labeled.
(B) Sequence alignment of the HAUSP TRAF-like domain with other TRAF
family members. Conserved residues are shown in yellow. Residues that
interact with p53 through hydrogen bonds and van der Waals contacts
are identified by green arrow heads and green squares, respectively.
Residues that interact with MDM2 through hydrogen bonds and van der
Waals contacts are indicated by red arrow heads and red squares,
respectively. Conserved residues that are involved in binding to peptides
in other TRAF family proteins, but not in HAUSP, are colored red and
indicated by purple background.
DOI: 10.1371/journal.pbio.0040027.g001
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Recognition of p53 and MDM2 by HAUSPserve to signiﬁcantly increase the effective protein concen-
tration.
Structural Basis of HAUSP Recognition by MDM2
Intriguingly, the minimal MDM2 fragment (residues 223–
232) required for binding to HAUSP exhibited little sequence
homology to the p53 fragment that interacts with the same
domain of HAUSP. To elucidate the mechanism by which
MDM2 recognizes HAUSP, we sought to determine the
structure of HAUSP TRAF-like domain bound to the minimal
MDM2 fragment. After many unsuccessful trials, we once
again succeeded by engineering a chimeric protein with the
Figure 2. Structural Basis of p53 Recognition by HAUSP
(A) Identification of a short-peptide fragment in p53 (residues 359–362) as the HAUSP-binding element. Various p53 fragments were individually
incubated with HAUSP protein (residues 53–206) and their interactions were examined by gel filtration. The results are summarized in the left panel.
Two representative experiments, for WT p53 (residues 325–367, WT) and mutant p53 (residues 325–367, S362A), are shown on the right panel. Note
that, because the elution volumes for free HAUSP (residues 53–206) and for free p53 (residues 325–367) correspond to fraction numbers 36 and 35,
these two proteins appear to co-migrate on gel filtration—but they do not interact with each other. The protein concentrations for gel filtration were:
HAUSP (53–206), 55 lM; p53 WT, 46 lM; p53 mutant, 51 lM.
(B) Overall structure of the HAUSP TRAF-like domain bound to p53 peptide is shown in a surface representation (left) and in a ribbon diagram (right).
Binding by the p53 peptide does not induce any significant conformational changes in HAUSP as shown by the structural comparison of the free and
p53-bound TRAF-like domain (right panel).
(C) A stereo view of the specific interactions between p53 and HAUSP. Hydrogen bonds are represented by red dashed lines. All interacting residues are
labeled.
DOI: 10.1371/journal.pbio.0040027.g002
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Recognition of p53 and MDM2 by HAUSPMDM2 peptide (residues 223–232) fused to the C-terminus of
the HAUSP TRAF-like domain (residues 53–197). We crystal-
lized this chimeric protein and solved its structure at 1.7-A ˚
resolution (Table 4 and Figure 4A).
In the structure of the HAUSP–MDM2 fusion protein, the
MDM2 peptide (residues 223–230) is bound to the shallow
surface groove on one side of the b-sandwich in the TRAF-
like domain, the same site where p53 binds. The MDM2
peptide assumes an extended main-chain conformation,
extending across strands b3, b4, b6, and b7 (Figure 4A). Five
residues in the MDM2 peptide, Asp225-Ala226-Gly227-
Val228-Ser229, make extensive polar and non-polar inter-
actions with the surface-binding residues from all four
strands, particularly strand b7 (Figure 4B). Although
Asp223, Leu224, and Glu230 of MDM2 adopt well-deﬁned
conformation in the structure, they do not make a direct
contribution to interactions with HAUSP.
A tt h eN - t e r m i n a le n do ft h eM D M 2p e p t i d e ,t h e
carboxylate side chain of Asp225 accepts a charge-stabilized
hydrogen bond from the guanidinium group of Arg152 in
HAUSP (Figure 4B). The main-chain conformation of Asp225
is stabilized by a pair of intra-molecular hydrogen bonds
between the carbonyl group of Asp223 and the amide groups
of Asp225 and Ala226. In the center of the MDM2 peptide,
three residues make a number of van der Waals interactions
to HAUSP. The side chain of Ala226 in MDM2 packs against a
hydrophobic pocket formed by the backbone Ca atom of
Gly166 and the side chains of Phe167, Trp165, and Ile154 in
HAUSP. The main-chain groups of Gly227 in MDM2 make
two hydrogen bonds to Gly166 in HAUSP, whereas the
backbone Ca atom of Gly227 is within van der Waals–contact
distance of the hydrophobic side chain of Trp165 in HAUSP.
The side chain of Val228 in MDM2 interacts with a hydro-
phobic-surface patch formed by the side chain of Trp165 and
the aliphatic portion of the side chains of Glu162 and Asp164
in HAUSP. At the C-terminal end of the MDM2 peptide,
Ser229 in MDM2 makes a total of three hydrogen bonds to
surface residues in HAUSP. The amide and the hydroxyl
groups of Ser229 donate two hydrogen bonds to the
carboxylate side chain of Asp164 in HAUSP, and the carbonyl
group of Ser229 accepts a hydrogen bond from the
guanidinium group of Arg104 in HAUSP (Figure 4B).
Comparison of HAUSP Binding by MDM2 and by p53
To compare the speciﬁc recognition of p53 and MDM2 by
HAUSP, we superimposed the structure of the HAUSP TRAF-
like domain bound to p53 peptide to that bound to MDM2.
This alignment resulted in a root-mean-square deviation
(RMSD) of 0.37 A ˚ for 134 aligned-backbone Ca atoms, with
the bound p53 and MDM2 peptides well superimposed to
each other (Figure 5A).
There are a number of common themes for the recognition
of p53 and MDM2 by HAUSP. Both p53 and MDM2 peptides
bind to the same surface groove in the HAUSP TRAF-like
domain, sharing similar overall orientation (Figure 5A and
5B). Two non-polar residues, Pro359 in p53 and Ala226 in
MDM2, are positioned at the same site upon binding to
HAUSP and make similar van der Waals contacts with a
hydrophobic-surface pocket near the edge of b-sandwich in
HAUSP. The residues following Pro359 in p53 and Ala226 in
MDM2 are both glycines, which are very well superimposed
and make conserved main-chain hydrogen bonds to Gly166 in
the b7 strand of HAUSP (Figure 5B and 5C). Another
conserved residue in both peptides is Ser362 in p53 and
Ser229 in MDM2, which in both cases make hydrogen bonds
to Asp164 in HAUSP and make van der Waals contacts to
Phe118 in HAUSP. Considering the multiple speciﬁc inter-
actions between this Ser residue and residues from HAUSP, it
is likely that this Ser plays an anchoring role in the speciﬁc
recognition of both p53 and MDM2 by HAUSP.
Despite these common features, important differences
exist for HAUSP binding by p53 and by MDM2, which
Table 4. Summary of Crystallographic Analysis
Data Analysis Dataset p53–HAUSP HAUSP–MDM2 HAUSP (53–560)
Data reduction Beamline NSLS X25 NSLS X25 CHESS-A1
Space group C2 P3221 C2221
Resolution (A ˚) 2.30 1.70 3.20
Unique reflections 15,182 16,752 22,308
Data redundancy 5.8 3.9 4.5
Completeness (%) 92.2 98.0 95.3
Completeness (outer shell) 73.6 92.7 96.7
I/r (outer shell) 38.3 (14.2) 15.6 (2.98) 11.9 (2.79)
Rsym (outer shell) 0.049 (0.151) 0.086 (0.275) 0.109 (0.445)
Refinement Resolution (A ˚) 20.0–2.30 20.0–1.70 20.0–3.2
Reflections (j F j . 0) 13,952 28,992 20,764
All atoms (solvent) 2,408 (107) 1,302 (183) 7,774 (0)
Rcryst/Rfree (%) 22.7/26.3 21.8/23.7 26.5/31.6
RMSD bond length (A ˚) 0.007 0.005 0.009
RMSD bond angle (8) 1.52 1.41 1.72
Ramachandran plot Most favored (%) 85.5 90.2 77.7
Additionally allowed (%) 14.1 9.8 18.4
Generously allowed (%) 0.4 0 3.3
Disallowed (%) 0 0 0.6
Rsym¼RhRi j Ih,i Ih j /RhRi Ih,i, where Ih is the mean intensity of the i observations of symmetry-related reflections of h. Rcryst¼
P
j Fobs Fcalc j /
P
Fobs, where Fobs¼FP, and Fcalc is the calculated protein-structure factor from the atomic model
(Rfree was calculated with 10% of the reflections). RMSD in bond lengths and angles are the deviations from ideal values.
DOI: 10.1371/journal.pbio.0040027.t004
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Recognition of p53 and MDM2 by HAUSPexplain the competitive edge of MDM2 over p53. Gly361 in
p53, which does not directly interact with HAUSP, is
substituted by Val228 in MDM2, resulting in additional van
der Waals contacts with Trp165 and Glu162 in HAUSP
(Figure 4B). Perhaps more importantly, Asp225 in MDM2
makes a direct hydrogen bond to Arg152 and a water-
mediated hydrogen bond to Ser168 in HAUSP; yet such
interactions are absent in the case of p53. Compared to p53,
the more extensive interactions between MDM2 and HAUSP
provide a mechanistic explanation to our biochemical
observation that MDM2 out-competed excess p53 for binding
to HAUSP.
Peptide Recognition by HAUSP
In this paper, we report the structural basis for the
differential recognition of p53 and MDM2 by HAUSP.
HAUSP was previously known to bind to another protein
named EBNA1 [38,39], and the crystal structure of the
HAUSP TRAF-like domain bound to a peptide derived from
EBNA1 was recently reported [30]. The amino acid sequences
Figure 3. HAUSP Preferentially Forms a Stable HAUSP–MDM2 Complex in the Presence of Excess p53
(A) The TRAF-like domain of HAUSP is responsible for binding to MDM2. Various HAUSP fragments were individually incubated with MDM2 protein
(residues 170–423) and their interactions were examined by gel filtration. The results are summarized here.
(B) Identification of a minimal HAUSP-binding element in MDM2. Various MDM2 fragments were individually incubated with HAUSP TRAF-like domain
(residues 53–206) and their interactions were examined by gel filtration. The results are summarized here.
(C) HAUSP preferentially forms a stable HAUSP–MDM2 complex in the presence of excess p53. HAUSP (residues 1–206) interacts with both p53 (residues
351–382, upper panel) and MDM2 (residues 208–289, middle panel). However, in the presence of a 10-fold excess amount of p53, HAUSP formed a
stable complex only with MDM2 (lower panel). The relevant peak fractions were visualized by SDS-PAGE followed by Coomassie staining.
(D) Determination of binding affinities between the HAUSP TRAF-like domain (residues 53–206) and peptides derived from p53 and MDM2 by ITC. The
p53 and MDM2 peptides contain residues 351–382 and 208–242, respectively. The binding affinities for the p53 and MDM2 peptides are 3 and 21 lM,
respectively.
DOI: 10.1371/journal.pbio.0040027.g003
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Recognition of p53 and MDM2 by HAUSPof the three HAUSP-binding peptides, PGGSR in p53,
DAGVSE in MDM2, and PGEGPS in EBNA1, share no obvious
sequence homology with each other; however, they all bind to
the same surface groove on the TRAF-like domain of HAUSP
(Figure 5B). Comparison of these three structures reveals how
HAUSP speciﬁcally recognizes all three distinct peptides.
Structure-based sequence alignment of the three HAUSP-
binding peptides revealed a conserved four-residue binding
motif with the consensus sequence of (Ø/E)-G-(Ø/G)-S, where
Ø denotes a non-polar residue (Figure 5C). In all three
structures, the four-residue motif, in an extended conforma-
tion, binds to the same substrate-recognition site on HAUSP
(Figure 5C) and makes conserved contacts with the protein
(Figure 5B). The ﬁrst residue, P1, in the binding motif is
either a non-polar residue such as Pro359 in p53, Ala226 in
MDM2, or Glu444 in EBNA1, which also has an aliphatic
portion in its side chain (Figure 5C). P1 makes van der Waals
interactions with a hydrophobic-surface pocket on one edge
of the b-sandwich in HAUSP. P2, an invariant Gly in all three
peptides, forms two main-chain hydrogen bonds with Gly166
in the b7 strand of HAUSP. P3, a hydrophobic residue in
MDM2 and EBNA1, stacks against a small hydrophobic-
surface patch on HAUSP. This residue is Gly in p53, resulting
in a loss of van der Waals interaction at the P3 position and
consequently contributing to a relatively low binding afﬁnity
[38] (Figure 3C). P4, an invariant Ser in all three peptides,
makes two hydrogen bonds to the carboxylate side chain of
Asp164 in HAUSP and contacts Phe118 from the b4 strand of
HAUSP. This analysis identiﬁes Ser at the P4 position as the
anchoring residue for speciﬁc binding of peptides to HAUSP.
The residues outside the central HAUSP-binding motif are
diverse, both in terms of their corresponding positions and in
terms of the interactions that they mediate (Figure 5B). Both
MDM2 and EBNA1, but not p53, contain extra HAUSP-
interacting residues at the N-terminal end of the motif. In
EBNA1 peptide, the N-terminal Pro442 and Gly443 run
parallel to the edge of the HAUSP b7 strand, forming
hydrogen bonds between the carbonyl group of Asp441 and
the side chain of Asn169 in HAUSP and between the carbonyl
group of EBNA1 Pro442 and the amide group of Ser168 in
HAUSP [30]. Moreover, Pro442 has additional hydrophobic
contacts with Phe167 in HAUSP. These additional interac-
tions are very different from those between MDM2 and
HAUSP (Figure 4B) but explain why EBNA1 out-competes
p53 for binding to HAUSP [30].
The fact that most of the conserved peptide-binding
residues in TRAFs are no longer present in the structure of
the HAUSP TRAF-like domain (Figure 1B) indicates that the
TRAF-like domain of HAUSP represents a new peptide-
binding motif in the TRAF family. Supporting this notion, the
minimal HAUSP-binding motif does not match any of the
known TRAF-binding sequences, including the major con-
sensus sequence of (P/S/A/T)X(Q/E)E and the minor consensus
sequence of PXQXXD for TRAF1, 2, 3, and 5 [33,36], and the
TRAF6-binding motif of PxExx(¢/acidic) [34].
Coordination of Substrate Recognition and
Deubiquitylation by HAUSP
HAUSP is a representative member of the UBP family of
DUBs, which are known to recognize speciﬁc substrates for
deubiquitylation. The recognition of a substrate is expected
to be coupled to its deubiquitylation by HAUSP. However,
there is a complete lack of understanding for this process at
the present time, despite the fact that the structure of the
catalytic core domain of HAUSP has already been deter-
mined [29]. To investigate this process, we sought to
determine the crystal structure of a larger HAUSP fragment
(residues 53–560), which contains both the substrate-binding
TRAF-like domain and the catalytic core domain. We
succeeded in the generation of crystals for this HAUSP
fragment and solved its structure at 3.2 A ˚ -resolution (Table
4). The structure contains two well-ordered domains, the
TRAF-like domain as a b-sandwich and the isopeptidase
domain as a tripartite architecture (Figure 6A). Interestingly,
there is very limited interaction between these two domains,
and the intervening linker sequences (residues 199–206) have
high-temperature factors in the crystals, suggesting that the
substrate-binding domain is coupled to the catalytic domain
through a relatively ﬂexible linker sequence. In addition, the
ubiquitin-binding pocket of the catalytic core domain and
the substrate-binding groove of the TRAF-like domain are
located on the same side of the molecule (Figure 3).
On the basis of the structure and previous information
about ubiquitin binding [29], we modeled how HAUSP may
recognize an ubiquitylated MDM2 molecule (Figure 6B). In
this model, a small peptide region (residues 225–230) of
MDM2 anchors its binding to the TRAF-like domain of
HAUSP. A conjugated ubiquitin moiety is bound by the
Fingers domain of HAUSP, with the C-terminus of ubiquitin
docked in the active-site cleft between the Palm and the
Figure 4. Structural Basis of MDM2 Recognition by HAUSP
(A) Overall structure of the HAUSP TRAF-like domain bound to MDM2
peptide is shown in a ribbon diagram (left) and in a surface
representation (right). The important MDM2 residues are highlighted in
yellow.
(B) A stereo view of the specific interactions between MDM2 and HAUSP.
These interactions are more extensive than those between p53 and
HAUSP. Hydrogen bonds are represented by red dashed lines. All
interacting residues are labeled.
DOI: 10.1371/journal.pbio.0040027.g004
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Recognition of p53 and MDM2 by HAUSPThumb (Figure 6B). The close proximity of the C-terminus of
HAUSP-bound ubiquitin and the MDM2 peptide suggests
that HAUSP likely prefers to cleave the ubiquitin chain at the
proximal end of the ubiquitylated MDM2.
Discussion
The critical role of HAUSP in regulating the p53–MDM2
pathway was ﬁrst revealed by the ﬁnding that HAUSP can
speciﬁcally recognize and deubiquitylate p53 both in vivo and
in vitro [24]. However, the concept of HAUSP as a speciﬁc
p53-stabilizing protein and candidate tumor suppressor was
challenged by the recent ﬁndings that HAUSP also speciﬁ-
cally recognizes MDM2 and stabilizes MDM2 through direct
deubiquitylation [27,28]. Based on these ﬁndings, a dynamic
role of HAUSP in the p53–MDM2 pathway was proposed [26].
However, the mechanisms by which HAUSP recognizes p53
and MDM2, as well as the exact role of HAUSP in the p53–
MDM2 pathway, remained enigmatic.
In this study, we report four important and novel ﬁndings.
First, the N-terminal TRAF-like domain of HAUSP/USP7 was
identiﬁed to speciﬁcally recognize both p53 and MDM2. This
ﬁnding also indicates that the substrate-recognition domain
of a UBP (such as HAUSP) may target more than one cellular
protein. Second, MDM2 binding to HAUSP was found to be
mutually exclusive with p53 binding to HAUSP. The HAUSP-
binding elements were mapped to a peptide fragment in the
carboxy-terminus of p53 and to a short-peptide region
preceding the acidic domain of MDM2. A minimal HAUSP-
binding peptide derived from MDM2 efﬁciently displaced
p53 from the p53–HAUSP complex in a competition assay
and formed a stable HAUSP–MDM2 complex. Third, the
molecular basis of HAUSP-mediated recognition of p53 and
MDM2 was revealed by the high-resolution crystal structures
of the HAUSP TRAF-like domain bound to peptides derived
from p53 and MDM2. Structural comparison reveals that
MDM2 recognizes the same surface groove in the HAUSP
TRAF-like domain as that made by the p53 peptide.
Compared to p53, MDM2 makes conserved, yet more
extensive, contacts with HAUSP. Last, but not least, structural
analysis reveals a consensus peptide sequence for HAUSP
recognition. This consensus sequence greatly facilitates any
effort aimed at identifying additional substrates for HAUSP/
USP7. For example, Hdmx, an MDM2 homologue, was shown
to bind to HAUSP [40]; examination of the primary
sequences of Hdmx identiﬁed a consensus HAUSP-binding
peptide, A470GAS473. Such analysis also identiﬁes the TRAF-
like domain in HAUSP as a new class of peptide-binding
TRAF domain.
Our studies provide an important framework for under-
standing the function of HAUSP in the p53–MDM2 pathway.
Although HAUSP can bind to p53, our competition data
suggest that HAUSP exhibits a higher binding afﬁnity for
MDM2, which likely translates into a stronger preference for
MDM2 deubiquitylation and stabilization. This conclusion
further suggests that MDM2 may represent a better substrate
for HAUSP activity under physiological conditions and
argues for a critical role of HAUSP in antagonizing the
auto-ubiquitylation function of MDM2. This analysis is fully
Figure 5. Structural Comparison of Peptide Binding by HAUSP Reveals a Consensus Sequence
(A) MDM2 peptide (red) binds to the same surface groove as the p53 peptide (magenta). Residues from MDM2 and p53 are shown in yellow and green,
respectively.
(B) Superposition of three HAUSP-binding peptides derived from MDM2 (red), p53 (magenta), and EBNA1 (green). The HAUSP TRAF-like domain is
shown in a transparent surface representation, with critical residues shown in brown.
(C) Structural alignment of HAUSP-binding peptides reveals a consensus sequence. The HAUSP surface groove (in a transparent surface representation)
for binding to the consensus tetrapeptide is shown in the left panel. The consensus sequence is shown in the right panel.
DOI: 10.1371/journal.pbio.0040027.g005
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Recognition of p53 and MDM2 by HAUSPconsistent with the observation that p53 is stabilized but
MDM2 is destabilized in HAUSP-ablated cells [26–28].
For a given protein such as MDM2 or p53, ubiquitylation
frequentlyoccurstomultipleLysresiduesthatarespreadoutin
theprimary sequences and inspace.Inthiscase,howcan a UBP
effectively deubiquitylate at multiple sites? The answer to this
question is inferred from our current study. First, it is possible
that a given protein may contain multiple binding sites for the
corresponding UBP. Supporting this notion, a consensus
HAUSP-binding element contains only four amino acids, (Ø/
E)-G-(Ø/G)-S, which predicts a statistically reasonable chance
for ﬁnding additional sites in the same protein. Indeed, an
examination of the complete human MDM2 sequence revealed
two additional candidate HAUSP-binding elements,
D117SGTS121 and L129EGGS133. Thus the presence of multi-
ple HAUSP-recognition sites in a given protein may greatly
facilitateefﬁcientdeubiquitylation.Althoughp53containsonly
one HAUSP-binding site, it forms a tetramer in cells and thus
generatesfourpotentialbindingsitesforHAUSP.Interestingly,
however, the tetrameric p53 fragment appeared to interact
with only one HAUSP molecule (Figure 2A), presumably owing
to structural constraint. Second, the linker sequence between
the TRAF-like domain and the catalytic domain is ﬂexible
(Figure 6A),which allowssome lateralmovement between these
two domains and hence enhanced access to multiple ubiquity-
lation sites within the same substrate.
It is worth noting that the consensus peptide sequence for
HAUSP binding has Ser, which can be phosphorylated, as an
anchoring residue. This residue makes a conserved hydrogen
bond to the negatively charged Asp164 in p53 (Figure 2), in
MDM2 (Figure 4), and in EBNA1 [30]. Structural analysis
suggests that phosphorylation of this Ser residue may have a
negative effect on its ability to contribute to HAUSP binding.
The interactions between HAUSP and p53 or MDM2 are
likely to be more complex in vivo, not only due to the
presence of multiple binding sites in MDM2 but also because
of the oligomeric nature of p53 and possibly HAUSP.
Although HAUSP was shown to be a homogeneous monomer
in solution by analytical ultracentrifugation [38], recent data
suggested that HAUSP may form a homo-dimer in cells [41].
Nonetheless, HAUSP was found to bind to p53 monomer and
tetramer with similar binding afﬁnities [38], suggesting that
HAUSP may not exhibit a strong preference to any speciﬁc
oligomeric form of p53. This notion is consistent with our
biochemical and structural observations (Figure 2), which
demonstrate that the HAUSP-binding element of p53
(residues 359–362) is located C-terminal to the tetrameriza-
tion domain (residues 325–355).
Finally, our studies also have important ramiﬁcations for
potential drug screening. Since HAUSP plays an essential role
in the stabilization of MDM2, the negative regulation of
HAUSP may lead to suppression of MDM2 activity, which in
turns stabilizes the tumor-suppressor protein p53. Our
current structural studies identify differential features for
HAUSP binding by MDM2 and by p53. For example, MDM2
contains an additional binding residue (Asp225) that makes
contacts to an area of HAUSP that is irrelevant for p53
binding (Figure 5B). Strategies can be devised to screen for
speciﬁc inhibitors that target this interface, thus destabilizing
HAUSP–MDM2 interactions. Additionally, because complete
inhibition of HAUSP is likely to have a far greater negative
effect on MDM2 over p53, the entire surface groove of the
HAUSP TRAF-like domain can be explored for inhibitor
design and screening. The available high-resolution struc-
tures should greatly facilitate this process. Such effort can be
carried out in conjunction with inhibitor screening aimed at
suppressing the isopeptidase activity of HAUSP.
Materials and Methods
Protein preparation. All constructs were generated using a stand-
ard PCR-based cloning strategy. The HAUSP TRAF-like domain
(residues 53–206) and the HAUSP long fragment (residues 53–560)
Figure 6. Structure of an Extended HAUSP Fragment
(A) Structure of a HAUSP fragment (residues 53–560) that contains both the substrate-binding (green) and the catalytic domains. Binding sites for
ubiquitin and substrate are indicated. The linker sequences between these two domains have high-temperature factors and are flexible in the crystals.
(B) A structure-based model showing HAUSP bound to an ubiquitylated MDM2. Only one ubiquitin moiety and the MDM2 peptide are shown in this
model.
DOI: 10.1371/journal.pbio.0040027.g006
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Recognition of p53 and MDM2 by HAUSPwere cloned into pGEX-2T (Pharmacia-LKB Technology, Uppsala,
Sweden), and were overexpressed in Escherichia coli strain BL21(DE3)
as N-terminally GST-tagged proteins. Seleno-Met-substituted HAUSP
TRAF-like domain (residues 53–206) was expressed in E. coli
B834(DE3) (Novagen, Madison, Wisconsin, United States) in M9
minimal medium supplemented with 50 mg/l of selenomethionine. To
generate the p53–HAUSP chimeric protein, the complementary DNA
sequence encoding the p53 peptide (residues 359–368) was inserted
into the sequence of the 39 primer used for the PCR reaction of the
HAUSP TRAF-like domain (residues 53–199). A similar strategy was
adopted to generate the HAUSP–MDM2 chimeric protein, in which
the MDM2 peptide (residues 223–232) was fused to the C-terminus of
the HAUSP N-terminal domain (residues 53–197). Both chimeric
proteins were cloned into the vector pGEX-2T (Pharmacia-LKB
Technology) and were overexpressed in BL21(DE3). All proteins were
puriﬁed to homogeneity as previously described [29].
Crystallization and structure determination of the HAUSP TRAF-
like domain. Crystals were grown by the hanging-drop vapor-
diffusion method by mixing the HAUSP protein (residues 53–206)
(;25 mg/ml) with an equal volume of reservoir solution containing
100 mM Tris (pH 8.0), 240 mM CaCl2, 20 mM (NH4)2SO4, and 6.5%
PEG4000 (w/v), at 12 8C. Small crystals appeared after 2–3 d and
continued to grow to full size in 3–4 wk. The crystals belong to the
space group P212121 and contain one molecule per asymmetric
unit. The unit cell has a dimension of a ¼ 45.17 A ˚ ,b¼ 52.24 A ˚ , and
c ¼ 63.65 A ˚ . Crystals were equilibrated in a cryoprotectant buffer
containing reservoir buffer plus 25% glycerol (v/v) and were ﬂash
frozen in a cold nitrogen stream at  170 8C. The native and multiple
anomalous dispersion (MAD) datasets were collected at National
Synchrotron Light Source (NSLS) beamlines X25 and X12C,
respectively. All X-ray-diffraction data described in this paper were
processed using the software Denzo and Scalepack [42]. The structure
was determined by MAD, using SOLVE [43], and the selenium sites
were reﬁned using MLPHARE [44]. All atomic models described in
this study were built using O [45] and were reﬁned using CNS [46].
Crystallization and structure determination of the p53–HAUSP
chimeric protein. Crystals were grown by the hanging-drop vapor-
diffusion method by mixing the protein (;20 mg/ml) with an equal
volume of reservoir solution containing 100 mM Tris (pH 7.5), 200
mM CaCl2, and 9% PEG2000 monomethylether (w/v). The crystals
belong to the space group C2, and contain two molecules per
asymmetric unit. The unit cell has a dimension of a ¼ 87.76 A ˚ ,b¼
39.56 A ˚ , and c ¼ 101.9 A ˚ , and b ¼ 105.3, and contains two molecules
per asymmetric unit. The native dataset was collected at NSLS X25.
The structure was determined by molecular replacement using
AMoRe [47] and was reﬁned at 2.3-A ˚ resolution.
Crystallization and structure determination of the HAUSP–MDM2
chimeric protein. Crystals were grown by the hanging-drop vapor-
diffusion method by mixing the protein (;15 mg/ml) with an equal
volume of reservoir solution containing 100 mM Tris (pH 8.5), 300
mM CaCl2, and 26% PEG4000 (w/v). The crystals belong to the space
group P3221 and contain one molecule per asymmetric unit. The unit
cell has a dimension of a¼37.53 A ˚ ,b¼37.53 A ˚ , and c¼177.3 A ˚ . The
native dataset was collected at NSLS X25. The structure was
determined by molecular replacement using AMoRe [47] and was
reﬁned at 1.7-A ˚ resolution.
Crystallization and structure determination of HAUSP (53–560).
Crystals were grown by the hanging-drop vapor-diffusion method by
mixing the protein (;15 mg/ml) with an equal volume of reservoir
solution containing 100 mM phosphate–citrate (pH 4.2), 0.8%
PEG10,000, and 50 mM 1,6-Hexandiol. Small crystals appeared after
2 d and were used as seeds to generate larger crystals. The crystals
belong to the space group C2221, and contain two molecules per
asymmetric unit. The unit cell has a dimension of a ¼ 97.63 A ˚ ,b¼
219.9 A ˚ , and c ¼ 130.5 A ˚ . The native dataset was collected at CHESS-
A1. The structure was determined by molecular replacement using
AMoRe [47] and was reﬁned at 3.2-A ˚ resolution.
In vitro binding assays using gel ﬁltration. Size-exclusion chroma-
tography (gel ﬁltration), using a Superdex-200 column (10/30,
Amersham Pharmacia Biotech, Piscataway, New Jersey, United
States), was employed to carry out all the in vitro binding assays.
Proteins subjected to binding tests were incubated at 4 8C for at least
45 min to allow equilibrium to be reached. The ﬂow rate was 0.5 ml/
min, and the buffer contained 25 mM Tris (pH 8.0), 100 mM NaCl,
and 2 mM DTT. All fractions were collected at 0.5 ml each. Aliquots
of relevant fractions were mixed with SDS sample buffer and
subjected to SDS-polyacrylamide gel electrophoresis. The proteins
were visualized by Coomassie Blue staining. The column was
calibrated with molecular-mass standards. For the competition
experiment (Figure 3C), 10-fold molar equivalence of the p53 peptide
was ﬁrst incubated with the HAUSP TRAF-like domain for 5 min at 4
8C, then the complex was further incubated with one molar
equivalence of MDM2 peptide for 45 min at 4 8C before the mixture
was subjected to gel ﬁltration analysis.
ITC. HAUSP N-terminal domain (residues 53–206), the p53
(residues 351–382) peptide, and the MDM2 (residues 208–242)
peptide were prepared in the buffer containing 10 mM HEPES (pH
8.0) and 100 mM NaCl. The Micro Calorimetry System (Microcal,
Amherst, Massachusetts, United States) was used to perform the ITC
measurements for the interaction between the HAUSP N-terminal
domain and the peptides. The titration data were collected at 4 8C
and were analyzed using the ORIGIN data-analysis software (Microcal
Software, Northampton, Massachusetts, United States).
Supporting Information
Accession Numbers
The Protein Data Bank (http://www.rcsb.org/pdb) accession numbers
for the atomic coordinates of the HAUSP TRAF-like domain alone,
the HAUSP TRAF-like domain bound to p53 and MDM2 peptides,
and HAUSP (residues 53–560) are 2F1W, 2F1X, 2F1Y, and 2F1Z,
respectively.
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